Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | VEGF | 731.0 | 70 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | VEGF | 596.0 | 74 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | VEGF | 489.0 | 69 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | VEGF | 572.0 | 59 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | VEGF | 701.0 | 49 | |
RA2159 | Sigma A6730 | 3.0 | uM | 1 | VEGF | 389.0 | 55 | ||||
N2586 | IL-6 | 100 | ug/mL | 1 | VEGF | 962.0 | 69 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | VEGF | 800.0 | 54 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | VEGF | 1011.0 | 48 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | VEGF | 1172.0 | 46 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | VEGF | 1098.0 | 66 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | VEGF | 1075.5 | 68 | |
N2586 | Sigma A6730 | 3.0 | uM | 1 | VEGF | 964.5 | 40 | ||||
RA2159 | IL-17A | 100 | ng/mL | 1 | VEGF | 683.0 | 53 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | VEGF | 570.0 | 61 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | VEGF | 579.0 | 71 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | VEGF | 801.0 | 56 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | VEGF | 562.0 | 52 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | VEGF | 685.5 | 64 | |
N2586 | IL-17A | 100 | ng/mL | 1 | VEGF | 1020.0 | 58 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | VEGF | 1186.0 | 50 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | VEGF | 1386.0 | 51 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | VEGF | 826.0 | 50 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | VEGF | 1159.0 | 58 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | VEGF | 714.0 | 78 |